1. Home
  2. PROK vs NEWP Comparison

PROK vs NEWP Comparison

Compare PROK & NEWP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PROK
  • NEWP
  • Stock Information
  • Founded
  • PROK 2015
  • NEWP 1972
  • Country
  • PROK United States
  • NEWP Canada
  • Employees
  • PROK N/A
  • NEWP N/A
  • Industry
  • PROK Biotechnology: Biological Products (No Diagnostic Substances)
  • NEWP
  • Sector
  • PROK Health Care
  • NEWP
  • Exchange
  • PROK Nasdaq
  • NEWP Nasdaq
  • Market Cap
  • PROK 237.4M
  • NEWP 262.4M
  • IPO Year
  • PROK N/A
  • NEWP N/A
  • Fundamental
  • Price
  • PROK $1.54
  • NEWP $1.27
  • Analyst Decision
  • PROK Buy
  • NEWP Strong Buy
  • Analyst Count
  • PROK 5
  • NEWP 1
  • Target Price
  • PROK $4.50
  • NEWP $5.00
  • AVG Volume (30 Days)
  • PROK 430.9K
  • NEWP 228.8K
  • Earning Date
  • PROK 11-12-2024
  • NEWP 02-11-2025
  • Dividend Yield
  • PROK N/A
  • NEWP N/A
  • EPS Growth
  • PROK N/A
  • NEWP N/A
  • EPS
  • PROK N/A
  • NEWP N/A
  • Revenue
  • PROK N/A
  • NEWP N/A
  • Revenue This Year
  • PROK N/A
  • NEWP N/A
  • Revenue Next Year
  • PROK N/A
  • NEWP N/A
  • P/E Ratio
  • PROK N/A
  • NEWP N/A
  • Revenue Growth
  • PROK N/A
  • NEWP N/A
  • 52 Week Low
  • PROK $1.18
  • NEWP $0.87
  • 52 Week High
  • PROK $4.44
  • NEWP $2.53
  • Technical
  • Relative Strength Index (RSI)
  • PROK 37.52
  • NEWP 31.26
  • Support Level
  • PROK $1.70
  • NEWP $1.52
  • Resistance Level
  • PROK $2.03
  • NEWP $1.60
  • Average True Range (ATR)
  • PROK 0.21
  • NEWP 0.09
  • MACD
  • PROK -0.04
  • NEWP -0.02
  • Stochastic Oscillator
  • PROK 0.74
  • NEWP 4.55

About PROK ProKidney Corp.

ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's own cells isolated from the patient intended for treatment. Its lead product candidate, REACT (Renal Autologous Cell Therapy) is a disease-modifying cell therapy made from a patient's own renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. The company's pipeline consists of development program for severe diabetic kidney disease.

About NEWP New Pacific Metals Corp.

New Pacific Metals Corp is a Canadian Mining Issuer, in the business of exploring and developing precious metal properties in Bolivia. The company's projects which are also its reportable segments include Silver Sand; Carangas and Silverstrike.

Share on Social Networks: